Borneol.

Berberine has notoriously low oral availability, held back by efflux and rapid first-pass handling. Borneol has been shown in animal and cell work to loosen tight junctions and raise the apparent permeability of co-dosed compounds. The classical role of borneol in formulas is exactly this, as a guiding agent added in small amounts to carry other constituents. Human pharmacokinetic confirmation of the pair is lacking, so read it as mechanistic.

Animal work reports that borneol transiently increases blood-brain barrier permeability, and formulators have used it alongside neuroactive botanicals for that reason. Nothing has measured ginkgo terpene lactone brain exposure in people with and without borneol. The pairing is a formulation tradition supported by non-human permeability data, not a demonstrated human effect.

Curcumin's problem is solubility and rapid conjugation rather than membrane crossing alone, so a permeation enhancer only addresses part of it. Borneol has been included in experimental nasal and oral delivery systems for exactly this class of molecule. Evidence sits at the formulation-science level.

Menthol is the archetypal TRPM8 agonist and borneol acts on overlapping thermosensitive channels, which is why both read as cooling on skin and mucosa. Combined topically the sensory effect stacks, and so does the irritation potential on broken skin or mucous membranes. This is a sensory and formulation interaction. It says nothing about a systemic effect.

Bornyl esters and borneol itself potentiate GABA-A currents in cell work, and valerenic acid does the same at a different site on the receptor. Combining them in a night-time formula stacks two weak modulators at one receptor complex. Neither has strong human data at supplement doses, and the caution is more about layering sedating agents than about any expected benefit.

Melatonin shifts timing rather than sedating directly, but the practical experience of combining it with a GABA-active terpene is more grogginess than either alone in some people. The interaction is behavioural and unmeasured. Flagged so that anyone layering an evening stack counts both.

Borneol is absorbed quickly and conjugated to borneol glucuronide before renal excretion. Quercetin is heavily glucuronidated on the same enzyme family. High co-doses can in principle slow each other's clearance. This is inferred from shared metabolic route rather than measured for this pair, so the confidence stays low.

Borneol dissolves readily in oils and alcohols and barely at all in water, so any oral or topical preparation needs a lipid or alcoholic vehicle to get it into solution and keep it there. Carrier oils also slow evaporative loss from topical preparations. This is formulation chemistry.